Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Discov Today. 2014 Oct;19(10):1587-94. doi: 10.1016/j.drudis.2014.05.003. Epub 2014 May 20.

Three dimensional human small intestine models for ADME-Tox studies.

Author information

1
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
2
Department of Chemical Engineering, Northeastern University, Boston, MA, USA.
3
Department of Biological and Environmental Engineering, Cornell University, Ithaca, NY, USA.
4
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: griff@mit.edu.

Abstract

In vitro human small intestine models play a crucial part in preclinical drug development. Although conventional 2D systems possess many advantages, such as facile accessibility and high-throughput capability, they can also provide misleading results due to their relatively poor recapitulation of in vivo physiology. Significant progress has recently been made in developing 3D human small intestine models, suggesting that more-reliable preclinical results could be obtained by recreating the 3D intestinal microenvironment in vitro. Although there are still many challenges, 3D human small intestine models have the potential to facilitate drug screening and drug development.

PMID:
24853950
DOI:
10.1016/j.drudis.2014.05.003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center